These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9394771)

  • 21. Are there more clinically important complications of Helicobacter pylori infection than peptic ulcer disease? A review of current literature.
    Unge P
    J Gastroenterol; 1998; 33 Suppl 10():48-52. PubMed ID: 9840018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori screening: options and challenges.
    Venerito M; Goni E; Malfertheiner P
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):497-503. PubMed ID: 26619972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori: a pathogenic threat to the gastric mucosal barrier.
    Oluwole FS
    Afr J Med Med Sci; 2015 Dec; 44(4):289-96. PubMed ID: 27462690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies.
    Pilotto A
    Drugs Aging; 2001; 18(7):487-94. PubMed ID: 11482742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori in peptic ulcer disease.
    NIH Consens Statement; 1994 Feb 7-9; 12(1):1-23. PubMed ID: 7920747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should we screen for Helicobacter pylori to prevent gastric cancer?
    Leja M; Dumitrascu DL
    Dig Dis; 2007; 25(3):218-21. PubMed ID: 17827943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is new related to Helicobacter pylori infection in children and teenagers?
    Kato S; Sherman PM
    Arch Pediatr Adolesc Med; 2005 May; 159(5):415-21. PubMed ID: 15867113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Helicobacter pylori eradication therapy does not prevent gastric cancer development in all patients].
    Take S; Ishiki K; Mizuno M
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):353-7. PubMed ID: 21403436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy.
    Czesnikiewicz-Guzik M; Loster B; Bielanski W; Guzik TJ; Konturek PC; Zapala J; Konturek SJ
    J Clin Gastroenterol; 2007 Feb; 41(2):145-51. PubMed ID: 17245212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and benefits of Helicobacter pylori eradication: current status.
    Hunt RH; Fallone C; Veldhuyzen van Zanten S; Sherman P; Smaill F; Thomson AB;
    Can J Gastroenterol; 2002 Jan; 16(1):57-62. PubMed ID: 11826340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori in intensive care: why we should be interested.
    Robertson MS; Clancy RL; Cade JF
    Intensive Care Med; 2003 Nov; 29(11):1881-8. PubMed ID: 14608460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori: epidemiology and routes of transmission.
    Brown LM
    Epidemiol Rev; 2000; 22(2):283-97. PubMed ID: 11218379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection.
    Fallone CA; Barkun AN; Göttke MU; Beech RN
    Can J Microbiol; 1998 Mar; 44(3):201-10. PubMed ID: 9606905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population screening and treatment of Helicobacter pylori infection.
    O'Connor A; O'Morain CA; Ford AC
    Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):230-240. PubMed ID: 28053340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori: host genetics and disease outcomes.
    Snaith A; El-Omar EM
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):577-85. PubMed ID: 19072405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Probiotics in Managing of Helicobacter Pylori Infection: A Review.
    Kafshdooz T; Akbarzadeh A; Majdi Seghinsara A; Pourhassan M; Nasrabadi HT; Milani M
    Drug Res (Stuttg); 2017 Feb; 67(2):88-93. PubMed ID: 27824431
    [No Abstract]   [Full Text] [Related]  

  • 39. Helicobacter pylori in children: an Indian perspective.
    Poddar U; Yachha SK
    Indian Pediatr; 2007 Oct; 44(10):761-70. PubMed ID: 17998576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.
    Maleki Kakelar H; Barzegari A; Dehghani J; Hanifian S; Saeedi N; Barar J; Omidi Y
    Gastric Cancer; 2019 Jan; 22(1):23-36. PubMed ID: 30145749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.